Understanding the diagnosis and treatment options empowered the patient, fostering a sense of control and preparedness. Maintaining a positive mental attitude and aligning with supportive healthcare ...
Conditional survival is the probability that a patient with a given disease will survive an additional number of years based on the fact that he or she has already survived a specific number of years.
Statin use in CLL/SLL patients treated with ibrutinib reduced cancer-related death risk by 61% and improved survival outcomes. The study found no significant increase in severe side effects with ...
Medical experts illustrate the impact of combination therapy for treatment of CLL and SLL. This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild, PharmD, MS, MBA, CPEL; Tara ...
SLL, also known as Studio LuluLala, announced a brand-new list of releases slated for the second half of the year and picked "popular appeal" as the keyword for its content in a press event Thursday. ...
NEW ORLEANS -- In patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL), progression-free survival (PFS) was significantly longer among those who ...
Approval is based on results from the BRUIN CLL-321 trial, the only randomized Phase 3 study in CLL/SLL in which all patients were previously treated with a covalent BTK inhibitor This expanded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results